USADA Press Releases http://www.usantidoping.org/ Current Press Releases for USADA AAA Panel Imposes Ban for Team Director Bruyneel, Team Doctor Celaya and Team Trainer Martí, for Involvement in The United States Postal Service (USPS) Pro Cycling Team Doping Conspiracy April 22, 2014

USADA announced today that a three-member, independent panel of the American Arbitration Association North American Court of Arbitration for Sport (AAA), rendered its decision in the case of Johan Bruyneel (Team Director), Dr. Pedro Celaya (Team Doctor) and Jose “Pepe” Martí (Team Trainer), finding that all three committed multiple anti-doping rule violations over many years.

The Panel found that “the evidence establishes conclusively that Mr. Bruyneel was at the apex of a conspiracy to commit widespread doping on the USPS and Discovery Channel teams spanning many years and many riders. Similarly, Dr. Celaya and Mr. Martí were part of, or at least allowed themselves to be used as instruments of, that conspiracy.”

“From the beginning, our investigation has focused on ridding cycling of those entrusted to care for the well-being of athletes who abuse their position of trust and influence to assist or encourage the use of performance-enhancing drugs to defraud sport and clean athletes,” said USADA CEO Travis T. Tygart. “There is no excuse for any team director, doctor or other athlete support person who corrupts the very sport and the athletes they are supposed to protect.”

The Panel imposed a ten-year ban for Bruyneel, and eight-year bans for Celaya and Martí as the result of their roles in the USPS Cycling Team Doping Conspiracy.

These three suspended individuals, together with the previously suspended Dr. Michele Ferrari, from Ferrara, Italy and Dr. Luis Garcia del Moral, of València, Spain (who each received lifetime suspensions), makes a total of five athlete support personnel from the USPS Pro Cycling Team to be suspended for anti-doping rule violations for their participation in the USPS Pro Cycling Team Doping Conspiracy.

The Panel found that Bruyneel trafficked in performance-enhancing drugs and “was engaged in the allocation of team-related resources… causing a variety of prohibited doping substances and methods to be used expressly for the purpose of gaining an unfair advantage for the teams and cyclists he managed in cycling events.” In addition, the Panel found that Bruyneel himself “profited considerably from the successes of the teams and riders he managed during the relevant period.” Bruyneel encouraged athletes to use doping products including EPO, blood transfusions, testosterone, and cortisone. Bruyneel, who currently lives in London, is a former Belgian cyclist who, after a long career as a cyclist on pro teams, was USPS team director from1999- 2007(team name was changed to the Discovery Channel Cycling Team for the period 2005-2007 due to a change in sponsorship). During 2008-2009 Bruyneel was Director of the Astana Cycling Team. Beginning in 2010 he became the Team Director (or Team Manager) for the RadioShack Team where he continued to work until USADA’s case was initiated.

Dr. Pedro Celaya is a Spanish doctor who worked in professional cycling as a Team Doctor for over a decade and currently lives in Elorrio, Spain. The Panel found that Dr. Celaya possessed and administered doping products, including EPO, blood transfusions, and cortisone. Celaya was a Team Doctor for the USPS/ Discovery Channel Pro Cycling Team from 1997 through 1998 and from 2004 through 2007.  During all or part of the period from 1999 through 2003 Dr. Celaya was a Team Doctor for the ONCE cycling team. Dr. Celaya continued to work in cycling as a Team Doctor for the RadioShack Nissan Trek Cycling Team until USADA’s case was initiated.

Jose “Pepe” Marti also was employed in professional cycling for over a decade and currently resides in València, Spain. The Panel found that Martí, a Team Trainer, trafficked performance enhancing drugs, including EPO, hGH, testosterone and cortisone to riders. Martí was involved in administering injections of EPO, testosterone, and hGH and in transfusing blood to riders.  Martí worked with the USPS and Discovery Channel Cycling Teams during the period from 1999 through 2007 and thereafter worked with the Astana Cycling Team. Most recently, Martí worked with one or more riders on Team Saxo Bank-Tinkoff Bank team until after USADA’s case was initiated.

Bruyneel, Celaya and Martí all chose to exercise their right to have their cases heard collectively by a panel of three independent arbitrators. Following a lengthy pre-hearing process including various motions filed by the respondents’ legal team, the four day evidentiary hearing took place in London, England in December of 2013.  The hearing was held in London at the request of Bruyneel, Celaya and Martí for their convenience.  Bruyneel, Celaya and Marti were collectively represented by seven lawyers at the hearing.  At the hearing, extensive and detailed evidence was presented to the Panel, and testimony was received from 17 witnesses, 14 of which were principally fact witnesses, including 8 cyclists, and 3 of which were expert witnesses. All of the witnesses testified under oath, and were subject to cross examination.

Bruyneel refused to testify and presented no fact witnesses on his own behalf. Martí likewise refused to testify.  Dr. Celaya did testify before the Panel and was subject to cross examination at the hearing. The Panel concluded that Dr. Celaya was not “a credible witness in this case.”

The Panel confirmed that, in accordance with the Code and the International Cycling Union Anti-Doping Rules (UCI ADR), USADA had authority to bring these cases, because USADA discovered the violations.

The AAA decision is available on the USADA website at http://www.usada.org/arbitration-decisions/.

Bruyneel’s sanction will end June 11, 2022 and Celaya and Martí’s sanctions will end on June 11, 2020.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

─ # ─

CONTACT:
Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org

]]>
http://www.usada.org/files/active/resources/pre ss_releases/Press Release-Bruyneel, Celaya, Marti - April 2014.pdf4/22/2014
AAA Arbitrator Imposes One-Year Sanction On US Track & Field Athlete, Davis, For Whereabouts Filing Violation April 21, 2014

USADA announced today that an independent arbitrator from the American Arbitration Association North American Court of Arbitration for Sport (AAA), has rendered a decision in the case of Walter Davis of Fresno, Texas, an athlete in the sport of track & field. The arbitrator found that Davis committed an anti-doping rule violation, and imposed a one-year suspension and loss of results for his failure to properly file his whereabouts information.

Davis, 34, became a member of the USADA Registered Testing Pool in 2001. The USADA Registered Testing Pool consists of a select group of athletes subject to certain whereabouts requirements in order to be located for USADA Out-of-Competition testing. Davis failed to keep USADA updated on his whereabouts and, as a result, accrued three Whereabouts Failures between July of 2012 and July of 2013.

Under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Association of Athletic Federations (IAAF) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code (“Code”), the combination of three Whereabouts Failures within an 18-month period constitutes a rule violation.

Davis’ one-year period of ineligibility, began on April 16, 2014. As a result of the violation, Davis has also been disqualified from all competitive results achieved on and subsequent to July 1, 2013, including forfeiture of any medals, points, and prizes.

The AAA decision is available on the USADA website at http://www.usada.org/arbitration-decisions/.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

─ # ─

CONTACT:
Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org

]]>
http://www.usada.org/files/active/resources/pre ss_releases/Walter Davis- April 2014.pdf4/21/2014
U.S. Track & Field Athlete, Carnes, Receives Sanction For Doping Violation April 18, 2014

USADA announced today that U.S. track & field athlete, Andrew Carnes, of Northfield, Ohio, has accepted a two-year period of ineligibility for a non-analytical anti-doping rule violation based on his purchase, possession and use of synthetic erythropoietin (EPO).

EPO, a synthetic hormone used to stimulate the body’s production of red blood cells, thereby increasing oxygen transport and aerobic power, is a prohibited substance in the class of Peptide Hormones, Growth Factors and Related Substances under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Association of Athletic Federations (IAAF) anti-doping rules, both of which have adopted the World Anti-Doping Code (“Code”) and the World Anti-Doping Agency Prohibited List.  

Carnes promptly admitted his violation to USADA, after being confronted with the evidence already in USADA’s possession. Carnes’ two-year period of ineligibility began on October 25, 2013, the day he accepted responsibility for his anti-doping rule violation. Additionally, Carnes is disqualified from all competitive results achieved on and subsequent to June 1, 2011, the date he first committed the anti-doping rule violation, including forfeiture of any medals, points and prizes.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

─ # ─

CONTACT:
Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org
]]>
http://www.usada.org/files/active/resources/pre ss_releases/Press Release - Carnes - April 2014.pdf4/18/2014
Brazilian Jiu-Jitsu Athlete, Garcia, Accepts Finding Of No Fault And Loss Of Results March 26, 2014

USADA announced today that Gabrielle Lemos Garcia of São Paulo, Brazil, an athlete in the sport of Brazilian jiu-jitsu, has tested positive for a prohibited substance, which was determined to have been ingested by her without fault or negligence, and will lose competitive results.

Garcia, 28, tested positive for Clomiphene as the result of an in-competition urine sample she provided on June 2, 2013 at the International Brazillian Jiu- Jitsu Federation (IBJJF) World Jiu-Jitsu Championships in Long Beach, Calif. USADA was contracted by IBJJF to conduct testing for the event and collected Garcia’s sample in accordance with the World Anti-Doping Agency International Standard for Testing.

Clomiphene is a prohibited substance in the category of “Hormone and Metabolic Modulators”  under the USADA Protocol for Olympic and Paralympic Movement Testing, which has adopted the World Anti-Doping Code (the “Code”) and the World Anti-Doping Agency Prohibited List. Clomiphene is classified as a Specified Substance, and therefore the presence of Clomiphene in an athlete’s sample can result in a reduced sanction.

After a thorough review of the case, USADA was able to conclude, to a comfortable satisfaction, that Garcia had not acted negligently and was not at fault for the positive test. Although Garcia was not found to be at fault or to have acted negligently, in accordance with the Code, a violation of the anti-doping rules in connection with an In-Competition test automatically leads to the disqualification of all results obtained in that competition.  While her results from the IBJJF World Jiu-Jitsu Championships shall be disqualified, Garcia did not receive a period of ineligibility and, in accordance with the Code, remains eligible to compete.
In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

─ # ─

CONTACT:
Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org

]]>
http://www.usada.org/files/active/resources/pre ss_releases/Press Release-Garcia March 2014.pdf3/26/2014
US Bowling Athlete, O’Keefe, Accepts Public Warning For Rule Violation USADA announced today that Shannon O’Keefe of Arlington, Texas, an athlete in the sport of bowling, has tested positive for a prohibited substance after using a prescribed medication, and has accepted a public warning for her rule violation.

O’Keefe, 35, tested positive for Clomiphene as the result of an out-of-competition urine sample collected on January 28, 2014. Clomiphene is a prohibited hormone under the USADA Protocol for Olympic and Paralympic Movement Testing and the World Tenpin Bowling Association (“WTBA”) anti-doping rules, both of which have adopted the World Anti-Doping Code (“Code”) and the World Anti-Doping Agency Prohibited List. Clomiphene is classified as a Specified Substance, and therefore the presence of Clomiphene in an athlete’s sample can result in a reduced sanction.

After a thorough review of the case, including the examination of medical records provided by the athlete, USADA has accepted O’Keefe’s explanation that the Clomiphene was not being used in an effort to enhance her performance and that she was taking the prescribed medication in a therapeutic dose under the care of a physician.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

─ # ─

CONTACT:
Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org
]]>
http://www.usada.org/files/active/resources/pre ss_releases/Press Release- OKeefe- March 2014.pdf3/14/2014
USADA & JADA Meet to Deepen Anti-Doping Partnership, and Create Further Opportunities for Cooperation & Sharing of Expertise March 4, 2014

The Japan Anti-Doping Agency (JADA) invited representatives from the United States Anti-Doping Agency (USADA) to meet, in order to share experience and best practices and to further our joint cooperative efforts. During the visit, which took place at JADA headquarters in Tokyo, Japan, both JADA and USADA agreed on further cooperation to maximise respective expertise and enhance the global anti-doping movement.

Travis T. Tygart, USADA CEO, and Dr. Matthew Fedoruk, USADA Science Director, visited Tokyo February 18-19 and met with Japan’s Deputy Director-General of the Ministry in charge of sport (Ministry of Education, Culture, Sports, Science and Technology, MEXT); JADA President, Prof. Hidenori Suzuki; and the President of the Japan Sport Council, Dr. Ichiro Kono and the Council’s Anti-Doping Group members. USADA also delivered a presentation to the JADA staff members and scientific and medical experts of the Tokyo-based Athlete Passport Management Unit (APMU) on the topic of longitudinal data collection and the biological passport program.

JADA CEO, Shin Asakawa, Testing Senior Manager, Chika Hirai, and Strategy & Planning and Education Senior Manager, YaYa Yamamoto, also met with Mr. Tygart and Dr. Fedoruk to discuss the continued collaboration between the two organizations. Mr. Tygart stressed the significance of sharing expertise and making use of mutual strengths of both National Anti-Doping Organizations (NADOs). In June of 2013, JADA became the first licensee of Global Drug Reference Online (Global DRO) to use a non-Roman-alphabet language. Global DRO is a robust resource, originally created by USADA, in partnership with UK Anti-Doping and the Canadian Centre for Ethics in Sport, to assist athletes in determining the prohibited status of medications. With over 35,000 hits in the first 7 months after launch in Japan, USADA and the JADA Global DRO project team continue to develop Global DRO Japan functionality, including educational resources for the athletes and over 5,000 Japan-based sports pharmacists, and plan future developments.

Mr. Tygart and Dr. Fedoruk visited the MEXT government office and met with Mr. Nagayama, Deputy Director General of Sports and Youth Bureau. With the 2015 World Anti-Doping Code coming into effect, Mr. Tygart stressed the important role intelligence and investigations play in successfully detecting and deterring doping in sport, and the key importance of building effective relationships between public authorities and NADOs. They also shared thoughts and discussed recent social science research on bridging the cultural divide between the anti-doping movement and the sport community, as well as enhancing deterrence and fostering relationships with key stakeholders outside of sport.
“International cooperation is an important part of our mission at USADA, and for the global anti-doping movement as a whole,” said USADA CEO Travis T. Tygart. “We have a strong relationship with our partners at JADA, and we appreciated their invitation to meet and explore further opportunities for continued collaboration.”

Now that the Japan Sport Council (JSC) has responsibility for anti-doping after the JSC’s legislation was revised in 2013, the JSC works in close cooperation with JADA to ensure sport integrity, and strengthen Japan’s anti-doping program to incorporate intelligence and investigation capabilities. Dr. Ichiro Kono, JSC President, congratulated USADA’s dedication to clean sport, and told Mr. Tygart and Dr. Fedoruk that Japan faces a pivotal time with planning for the upcoming Tokyo 2020 Games; that the Games success hinges on implementing an effective and state-of-the-art anti-doping program to preserve the rights of athletes to participate in clean sport; and that the success of a clean games is important to the reputation of Japan.

Prof. Suzuki was delighted to continue the cooperative relationship with USADA, stressing that: “We have many elements to learn, particularly including the effective use of intelligence and investigations to build capacity in strengthening anti-doping programs. Now that we have responsibility for the success of the Tokyo 2020 Games, I believe that the stronger collaboration with USADA will assist us in promoting best practices not only domestically, but regionally in Asia. We also look forward to building our collaborations in such areas as research, and sharing information and knowledge to protect clean sport and clean athletes.”

About:

Japan Anti-Doping Agency (JADA)

The Japan Anti-Doping Agency (JADA) was founded in 2001 as the cooperative effort of all stakeholders in Japan. Supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), JADA endeavours to lead the anti-doping activity with its key activity areas of education, awareness raising, research, doping control and the JADA Sports Pharmacist Program. It strives to promote and strengthened a value-based education programme in Japan in view of development of people and society through sport. 
http://www.playtruejapan.org/

United States Anti-Doping Agency (USADA)
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use necessary medications, and the risks and dangers of taking supplements as well as performance-enhancing drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.


]]>
http://www.usada.org/files/active/resources/pre ss_releases/JADA and USADA visit release.pdf3/4/2014
U.S. Judo Athlete, Atkinson, Accepts Sanction For Anti-Doping Rule Violation February 28, 2014

USADA announced today that Annie Atkinson, of Kent, Wash., an athlete in the sport of judo, has tested positive for a prohibited substance and has accepted a three-month suspension for her anti-doping rule violation.

Atkinson, 22, provided an out-of-competition urine sample on December 12, 2013, that resulted in an adverse analytical finding for Hydrochlorothiazide, Chlorothiazide, Triamterene and its metabolite 4-hydroxytriamterene which are in the class of diuretics and other masking agents prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Judo Federation (IJF) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code and the WADA Prohibited List. Hydrochlorothiazide, Chlorothiazide, Triamterene and its metabolite 4-hydroxytriamterene are classified as Specified Substances, and therefore the presence of the substances in an athlete’s sample can result in a reduced sanction.

Atkinson’s three-month period of ineligibility began on December 12, 2013, the date her urine sample was collected.  As a result of the violation, Atkinson has been disqualified from all competitive results achieved on and subsequent to December 12, 2013, including forfeiture of any medals, points, and prizes.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

─ # ─

CONTACT:
Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org
]]>
http://www.usada.org/files/active/resources/pre ss_releases/Press Release-Atkinson-February2014.pdf2/28/2014
US Speed Skating Athlete, Perry, Accepts Sanction For Anti-Doping Rule Violation February 26, 2014

USADA announced today that Brett Perry, of Midvale, Utah, an athlete in the sport of speed skating, has tested positive for a prohibited substance and accepted a nine-month suspension for his offense.

Perry, 21, tested positive for Methylphenidate and its metabolite, Ritalinic Acid, as the result of an in-competition urine sample collected at the U.S. Olympic Trials on December 28, 2013. Methylphenidate is a stimulant prohibited in-competition under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Skating Union (“ISU”) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code (“Code”) and the World Anti-Doping Agency Prohibited List. Methylphenidate is classified as a Specified Substance, and therefore the presence of that substance in an athlete’s sample can result in a reduced sanction.

Perry was taking medication in a therapeutic dose under the care of a physician and although he disclosed that information during the sample collection, he did not follow the Therapeutic Use Exemption (TUE) requirements prior to competing.

Perry’s nine-month period of ineligibility began on December 28, 2013, the date the sample was collected. As a result of the violation, Perry has been disqualified from all competitive results achieved on and subsequent to December 28, 2013, including forfeiture of any medals, points, and prizes.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

─ # ─

CONTACT:
Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org


]]>
http://www.usada.org/files/active/resources/pre ss_releases/Press Release - Perry - February 2014.pdf2/26/2014
AAA Arbitrator Imposes Four-Month Sanction On Ethiopian Track & Field Athlete, Beyene, For Doping Violation February 21, 2014

USADA announced today that an independent arbitrator from the American Arbitration Association North American Court of Arbitration for Sport (AAA), has rendered a decision in the case of track & field athlete Hirut Beyene. The arbitrator found that Beyene committed an anti-doping rule violation, and imposed a four-month suspension and loss of results for her offense.

Beyene, 21, is originally from Ethiopia and was living and training in New York City, N.Y., when she provided a urine sample after participating in the Dick’s Sporting Goods Pittsburgh Marathon on May 5, 2013. Her sample resulted in an Adverse Analytical Finding for the stimulant Methylhexaneamine. Stimulants are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Association of Athletic Federations (IAAF) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code and the WADA Prohibited List. Methylhexaneamine is classified as a Specified Substance, and therefore the presence of that substance in an athlete’s sample can result in a reduced sanction.

The AAA arbitrator determined that Beyene had met the burden necessary to establish that her positive test was the result of the use of a contaminated supplement and that a four-month period of ineligibility was appropriate in this case. Beyene’s period of ineligibility began on October 7, 2013, the day she accepted a provisional suspension and ended on February 7, 2014. As a result of the violation, Beyene has also been disqualified from all competitive results achieved on and subsequent to May 5, 2013 through the commencement of her provisional suspension, including forfeiture of any medals, points, and prizes.

The AAA decision is available on the USADA website at http://www.usada.org/arbitration-decisions/

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

─ # ─

CONTACT:
Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org

 
]]>
http://www.usada.org/files/active/resources/pre ss_releases/Press Release- Beyene-February 2014.pdf2/21/2014
Statement From USADA CEO Travis T. Tygart On The Designer Anabolic Steroid Control Act Introduced Today By Senators Hatch And Whitehouse February 11, 2014

“The legislation introduced today by Senators Hatch and Whitehouse is an important step in helping to protect athletes at all levels, parents and all consumers from unscrupulous companies who are selling dangerous designer steroids disguised as supplements.  As part of our mission for clean athletes, we work to help athletes understand the risks associated with supplement use, and we look forward to continuing to work with our Congressional leaders as they help ensure that the laws of this country can safeguard the public.”

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

─ # ─

CONTACT:

Annie Skinner, Media Relations Manager
Phone: (719) 785-2046
E-mail:  askinner@usada.org

]]>
http://www.usada.org/files/active/resources/pre ss_releases/News Release - Statement from USADA CEO Travis T. Tygart on Designer Steroid Control Act 2013.pdf2/11/2014
US Cycling Athlete, Marte, Accepts Sanction For Anti-Doping Rule Violation February 3, 2014 

USADA announced today that Cesar Marte, of Fort Lee, N.J., an athlete in the sport of cycling, has tested positive for a prohibited substance and accepted a two-year suspension for his doping offense.

Marte, 21, provided a urine sample on July 21, 2013, during an in-competition test, at the CRCA Lou Maltese Memorial in New York, N.Y., that resulted in an adverse analytical finding for the prohibited stimulant Modafinil. Modafinil is prohibited in-competition under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Cycling Union (UCI) anti-doping rules, both of which have adopted the World Anti-Doping Code (“Code”) and the World Anti-Doping Agency Prohibited List.

Marte’s two-year period of ineligibility began on August 26, 2013, the date he accepted a provisional suspension. As a result of the violation, Marte has been disqualified from all competitive results achieved on and subsequent to July 21, 2013, the date the sample was collected, including forfeiture of any medals, points, and prizes.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

─ # ─

CONTACT:
Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org
]]>
http://www.usada.org/files/active/resources/pre ss_releases/Press Release-Marte-February2014.pdf2/3/2014
US Cycling Athlete, Baker, Accepts Sanction for Anti-Doping Rule Violation January 24, 2014

USADA announced today that Daniel Baker, of Brighton, Mass., an athlete in the sport of cycling, has tested positive for a prohibited substance and accepted a two-year suspension for his offense.

Baker, 37, tested positive for the presence of an exogenous androgenic anabolic steroid and/or its metabolites, which was confirmed by CIR (GC/C/IRMS) analysis, as the result of an in-competition urine sample collected September 29, 2013, at the Grand Prix of Gloucester.  Anabolic Androgenic Steroids are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Cycling Union (“UCI”) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code (“Code”) and the World Anti-Doping Agency Prohibited List.

Baker was taking synthetic testosterone in a therapeutic dose under the care of a physician and although he disclosed that information during the sample collection, he did not follow the Therapeutic Use Exemption (TUE) requirements prior to competing.

Baker’s two-year period of ineligibility began on September 29, 2013, the date the sample was collected. As a result of the violation, Baker has been disqualified from all competitive results achieved on and subsequent to September 29, 2013, including forfeiture of any medals, points, and prizes.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

─ # ─

CONTACT:
Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org

]]>
http://www.usada.org/files/active/resources/pre ss_releases/Press Release-Baker-January 2013.pdf1/24/2014
Michael Pearlmutter named Partnership for Clean Competition executive director January 15, 2014

The Partnership for Clean Competition today announced the hiring of Michael Pearlmutter as executive director. In his role, Pearlmutter will oversee organizational strategy and daily operations – including budgeting, fundraising, business development, grant administration, scientific outreach and communication with the PCC board of directors and scientific advisory board.

“The PCC is committed to preserving the integrity and fairness of sport through the support and enhancement of independent scientific research, and Michael’s leadership will ensure that our operations are driven toward that mission,” said Rana Dershowitz, chairperson of the PCC board of governors and general counsel at the United States Olympic Committee. “I am confident he will build on the work of our former executive director, Charlene Boudreau, as the PCC enters a new period of expansion and deepening impact.”

“All of the PCC partner organizations recognize the value of innovation and the role that independent scientific research plays in advancing our collective capability to both detect and deter the use of dangerous performance-enhancing drugs in sport,” said Dr. Larry Bowers, chair of the PCC scientific advisory board and chief science officer of the U.S. Anti-Doping Agency. “We look forward to working with Michael as we continue the important work of advancing scientific discovery for the benefit of clean athletes and the integrity of sport.”

Pearlmutter joins the PCC from the North Carolina Institute of Political Leadership (IOPL), where he was instrumental in providing strategic vision and guidance for future community leaders for more than two years. He brings extensive entrepreneurial and management experience in both business and politics, having served in a number of senior roles for non-profit organizations and consulting firms, as well as for-profit organizations – including, Solutia, Inc., where he successfully developed financial and strategic models for new product lines and medical technology.

“I am honored to be a part of the PCC,” said Pearlmutter “The organization has played an instrumental role in supporting independent scientific research aimed at maintaining integrity in sport and that impact will only grow over the next few years. I am looking forward to leading the PCC through this next phase in our growth.”

Pearlmutter received his bachelor’s degree in quantitative economics from the United States Naval Academy and his master’s in business administration from Babson College.

Pearlmutter assumed his new position on Jan. 2 and will be based in Colorado Springs, Colo.

About PCC
PCC was founded in 2008 by the U.S. Olympic Committee, the National Football League, Major League Baseball and the U.S. Anti-Doping Agency, and is recognized by the Internal Revenue Service as a 501(c)(3) non-profit public charity. PCC strives to protect the integrity of sport and public health by engaging and supporting the world’s top scientists and innovators in high-quality anti-doping research and development, and aspires to demonstrate the value of science, collaboration and innovation related to doping control in sport and ensuring the benefits of sport participation worldwide.  For more information, visit cleancompetition.org.


]]>
http://www.usada.org/files/active/resources/pre ss_releases/PCC ED 1 15 14_FINAL.pdf1/15/2014
US Weightlifting Athlete, Robles, Receives Sanction For Anti-Doping Rule Violation January 14, 2014

USADA announced today that Sarah Robles, of San Tan Valley, Ariz., an athlete in the sport of weightlifting, has tested positive for a prohibited substance and received a two-year suspension for her doping offense.

Robles, 25, tested positive for the presence of an exogenous androgenic anabolic steroid and/or its metabolites, which was confirmed by CIR (GC/C/IRMS) analysis, as the result of one out-of-competition and two in-competition urine samples collected by both USADA and the International Weightlifting Federation (“IWF”). Anabolic Androgenic Steroids are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the IWF Anti-Doping Rules, both of which have adopted the World Anti-Doping Code (“Code”) and the World Anti-Doping Agency Prohibited List. In accordance with the rules, since all three samples were collected in short succession and prior to notification of the first positive result, the three adverse analytical findings were treated as one offense.

Robles’ two-year period of ineligibility began on August 8, 2013, the date the IWF imposed a provisional suspension. As a result of the violation, Robles has been disqualified from all competitive results achieved on and subsequent to May 31, 2013, the date the first sample was collected, including forfeiture of any medals, points, and prizes.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

─ # ─

CONTACT:
Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org
]]>
http://www.usada.org/files/active/resources/pre ss_releases/Press Release- Robles- January 2014.pdf1/14/2014
Statement from USADA CEO Travis T. Tygart on the Alex Rodriguez Arbitration Ruling January 11, 2014

“This ruling sends a powerful message that no one is above the rules or bigger than the game. Commissioner Selig, Rob Manfred and their team should be commended for having the resolve and commitment to clean athletes to see tough cases like this through, so that justice prevails, and so that sophisticated and well-resourced athletes, who might be able to avoid detection through routine testing, do not get away with defrauding their competitors, teams or fans.”

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

CONTACT:
Annie Skinner, Media Relations Manager
Phone: (719) 785-2046
E-mail:  askinner@usada.org

]]>
http://www.usada.org/files/active/resources/pre ss_releases/News Release - Statement from USADA CEO Travis T. Tygart on Alex Rodrigues ruiling 2013.pdf1/11/2014
US Cycling Athlete, LeDuc, Accepts Sanction For Anti-Doping Rule Violation December 30, 2013

USADA announced today that David LeDuc, of Willow Springs, N.C., an athlete in the sport of cycling, has tested positive for prohibited substances and accepted a two-year suspension for his anti-doping rule violation.

LeDuc, 62, tested positive for the presence of a steroid of exogenous origin, recombinant human erythropoietin (“rhEPO”) and amphetamine, a prohibited stimulant, as the result of an in-competition urine sample collected on September 6, 2013 at the Masters Road National Championships in Bend, Ore. Anabolic Androgenic Steroids, rhEPO, and amphetamines are all prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the UCI Anti-Doping Rules, both of which have adopted the World Anti-Doping Code (“Code”) and the World Anti-Doping Agency Prohibited List.

LeDuc’s period of ineligibility began on December 24, 2013, the date he accepted the sanction. As a result of the violation, LeDuc has been disqualified from all competitive results achieved on and subsequent to September 6, 2013, including forfeiture of any medals, points, and prizes.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

─ # ─

CONTACT:
Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org
]]>
http://www.usada.org/files/active/resources/pre ss_releases/PressRelease-LeDuc-December2013.pdf12/30/2013
AAA Panel Imposes 13-Month Sanction On U.S. Volleyball Athlete, Klineman, For Doping Violation December 20, 2013

USADA announced today that a three-member panel of the American Arbitration Association North American Court of Arbitration for Sport (AAA), rendered its decision in the case of Alexandra Klineman, of Manhattan Beach, Calif., an athlete in the sport of Volleyball. The AAA panel found that Klineman has committed an anti-doping rule violation, and will serve a 13-month suspension.

Klineman, 23, tested positive for the presence of an androgenic anabolic steroid or its precursors, which was confirmed by CIR (GC/C/IRMS) analysis, after three out-of-competition urine samples were collected by USADA. The AAA panel accepted Klineman’s explanation that her results were from the inadvertent ingestion of her mother’s DHEA supplement, and that her violation was not intentional cheating. Anabolic Androgenic Steroids are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Volleyball Federation (“FIVB”)Anti-Doping Rules, both of which have adopted the World Anti-Doping Code (“Code”) and the World Anti-Doping Agency Prohibited List. In accordance with the rules, since all three samples were collected in short succession and prior to notification of the first positive result, the three adverse analytical findings will be treated as one offense.

The AAA Panel determined that a 13-month sanction was appropriate given the mitigating circumstances of her case. Klineman’s period of ineligibility began on May 22, 2013 the day her first sample was collected.

The AAA decision is available on the USADA website at http://www.usada.org/arbitration-decisions/

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

─ # ─

CONTACT:
Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org

]]>
http://www.usada.org/files/active/resources/pre ss_releases/Press Release- Klineman-December 2013.pdf12/20/2013
US Track & Field Athlete, Akor, Accepts Sanction For Violation December 18, 2013

USADA announced today that Mary Akor of Gardena, Calif., an athlete in the sport of track & field, has tested positive for a prohibited substance and accepted a two-year sanction for her doping offense.

Akor, 37, tested positive for Clenbuterol as the result of an In-Competition urine sample collected on December 16, 2012 at the Maraton Gobernador in Mexicali, Baja California. Clenbuterol is a prohibited Anabolic Agent under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Association of Athletic Federations (IAAF) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code and the WADA Prohibited List.

Akor accepted a two-year period of ineligibility, which began on May 6, 2013, the date the laboratory provided notice of the positive sample to the IAAF. The IAAF, who collected the sample, referred the case to USADA for results management as Akor is a U.S. athlete. Akor has been disqualified from all competitive results obtained between December 6, 2012, the date her sample was collected, and November 5, 2013, the day she accepted her sanction, including forfeiture of any medals, points, and prizes.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

─ # ─

CONTACT:
Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org

 
]]>
http://www.usada.org/files/active/resources/pre ss_releases/Press Release-Akor-December 2013.pdf12/18/2013
US Cycling Athlete, Rogers, Accepts Sanction For Anti-Doping Rule Violation

Colorado Springs, Colo. (November 27, 2013) -


USADA announced today that Jason Rogers, of Mesquite, Texas, an athlete in the sport of cycling, has tested positive for a prohibited substance and accepted a nine-month suspension for his anti-doping rule violation.


Rogers, 28, tested positive for Methylhexaneamine, a prohibited stimulant, as the result of an in-competition urine sample collected by the International Cycling Union (UCI) on March 8, 2013 at the BMX Continental Championships in Oldsmar, Fla. Certain stimulants are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the UCI Anti-Doping Rules, both of which have adopted the World Anti-Doping Code (“Code”) and the World Anti-Doping Agency Prohibited List. Methylhexaneamine is classified as a Specified Substance, and therefore the presence of that substance in an athlete’s sample can result in a reduced sanction.


Rogers’ nine- month period of ineligibility began on March 8, 2013, the date his sample was collected. As a result of the violation, Rogers has been disqualified from all competitive results achieved on and subsequent to March 8, 2013, including forfeiture of any medals, points, and prizes.


In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

 

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

#

 

CONTACT:
Media Relations Manager

Phone: (719) 785-2000

E-mail:  media@usada.org
]]>
http://www.usada.org/files/active/resources/pre ss_releases/Press Release-Rogers-September2013.pdf11/27/2013
AAA Panel Imposes Two-Year Sanction On U.S. Cycling Athlete, Meeker, For Doping Violation

November 26, 2013


USADA announced today that a three-member panel of the American Arbitration Association North American Court of Arbitration for Sport (AAA), rendered its decision in the case of cyclist Richard Meeker, finding that Meeker committed an anti-doping rule violation, and will serve a two-year suspension.


Meeker, 51, of Corona Del Mar, Calif., provided a urine sample on September 6, 2012, after participating in the Masters Road Championships competition held September 5-9, 2012, in Bend, Ore. His sample resulted in an Adverse Analytical Finding for 19-norandrosterone and 19-noretiocholanolone, which are metabolites indicating the use of a prohibited anabolic steroid. Anabolic agents, including anabolic steroids, are prohibited under the World Anti-Doping Agency Prohibited List, which has been adopted by the USADA Protocol for Olympic and Paralympic Movement Testing and the rules of the International Cycling Union (UCI). 

 

Meeker’s two-year period of ineligibility began on September 6, 2012, the day his sample was collected. Meeker sought a reduction in his sanction during the AAA hearing, but the Panel declined to reduce his period of ineligibility after concluding that he had failed to establish the source of the prohibited substance in his sample. As a result of the doping violation, Meeker has also been disqualified from all competitive results achieved at and subsequent to the Masters Road Championships competition, including forfeiture of any medals, points, and prizes.


The AAA decision is available on the USADA website at http://www.usada.org/arbitration-decisions/


In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and psychoactive drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.


USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs


CONTACT:
Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org

 

]]>
http://www.usada.org/files/active/resources/pre ss_releases/Press Release- Meeker-November 2013.pdf11/26/2013
US Paralympic Cycling Athlete, Morelli, Accepts Sanction For Rule Violation November 15, 2013

USADA announced today that Shawn Morelli, of Leavenworth. Kan., an athlete in the sport of Paralympic cycling, has been cleared to return to competition after testing positive for a prohibited substance.

Morelli, 37, provided an in-competition urine sample following her time trial win at the Greenville SC Para-cycling Open on April 20, 2013.  The sample had a low level amount of a prohibited stimulant, Methylhexaneamine. Certain stimulants are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and International Paralympic Committee (“IPC”) Anti‐Doping Code, both of which have adopted the World Anti-Doping Code (“Code”) and the World Anti-Doping Agency Prohibited List. Methylhexaneamine is classified as a Specified Substance, and therefore the presence of that substance in an athlete’s sample can result in a reduced sanction.

After a full review of the facts surrounding Morelli’s case, USADA concluded that there were mitigating circumstances that indicated Morelli had inadvertently ingested the prohibited substance and substantially reduced her level of fault for the anti-doping rule violation. Accordingly, it was determined that Morelli, who had willingly accepted a provisional suspension on May 20, 2013, pending the resolution of USADA’s investigation, should immediately be allowed to return to competition.

Although USADA accepted Morelli’s explanation that her ingestion of Methylhexaneamine was inadvertent and not intended to enhance her performance, in accordance with the rules, all of Morelli’s competitive results achieved on April 20, 2013, the date her sample was collected, have been disqualified including forfeiture of any medals, points, and prizes.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

─ # ─

CONTACT:
Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org

]]>
http://www.usada.org/files/active/resources/pre ss_releases/Press Release-Morelli-November2013.pdf11/15/2013
Statement From USADA CEO, Travis T. Tygart, Regarding Ryder Hesjedal October 30, 2013

Statement From USADA CEO, Travis T. Tygart, Regarding Ryder Hesjedal

"As has been publicly reported, we can confirm that USADA, along with the Canadian Center for Ethics in Sport (CCES), interviewed cyclist, Ryder Hesjedal, earlier this year as part of our ongoing investigation into the sport of cycling.  Athletes like him, and others, who have voluntarily come in, taken accountability for their actions and have been fully truthful, are essential to securing a brighter future for the sport of cycling.  As in all cases, where there is actionable evidence of doping within the statute of limitations, we have imposed discipline and announced sanctions.  We continue our ongoing investigation into the sport of cycling, and have also been urging the UCI to take the decisive and transparent action it announced over a year ago to truly set the sport on a new foundation for the good of clean athletes.  We are hopeful and confident that the new UCI leadership will fulfill its promise of conducting a full and independent process to finally put this sport on a new path toward integrity that protects the rights of clean athletes, and believe strongly the time for this is now."

 

]]>
http://www.usada.org/files/active/resources/pre ss_releases/ 10/30/2013
US Track & Field Athlete, Camarena-Williams, Accepts Sanction For Rule Violation October 4, 2013

USADA announced today that Jillian Camarena-Williams of Tucson, Ariz., an athlete in the sport of track & field, has tested positive for a prohibited substance after using a prescribed medication, and has accepted a six-month sanction for her rule violation.

Camarena-Williams, 31, tested positive for Clomiphene as the result of an out-of-competition urine sample collected on July 1, 2013. Clomiphene is a prohibited hormone under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Association of Athletics Federations (IAAF) anti-doping rules, both of which have adopted the World Anti-Doping Code (“Code”) and the World Anti-Doping Agency Prohibited List. Clomiphene is classified as a Specified Substance, and therefore the presence of Clomiphene in an athlete’s sample can result in a reduced sanction.

After a thorough review of the case including medical records, USADA has accepted Camarena-Williams’ explanation that the Clomiphene was not being used in an effort to enhance her performance and that she was taking the prescribed medication in a therapeutic dose under the care of a physician.

Although Clomiphene is prohibited under the applicable rules, an athlete who provides documentation confirming the diagnosis of a valid medical need, may receive a Therapeutic Use Exemption (“TUE”). After Camarena-Williams was notified of her positive test, she applied for and was granted a TUE for Clomiphene. Under the applicable rules, athletes are to have obtained a TUE prior to using prohibited substances in order to avoid an anti-doping rule violation.

“This past June, after being unable to compete due to injury, my husband and I decided to start a family,” said Camarena-Williams. “Shortly thereafter I began taking a prescribed fertility medication called Clomiphene under the care of my doctor. Since being advised of my positive test, I have cooperated fully with USADA and the IAAF and have now been granted a TUE for this medication.  While I hope to one day return to training and competition, at this time my husband and I are focused on starting our family.  With all my heart I believe in USADA’s and IAAF’s clean sport policies, and I thank them for the hard work they do for our sport."

Camarena-Williams’ six-month period of ineligibility began on July 1, 2013, the day the sample was collected. In addition Camarena-Williams has been disqualified from all competitive results obtained on and subsequent to July 1, 2013, including forfeiture of any medals, points and prizes.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

─ # ─

CONTACT:
Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org

]]>
http://www.usada.org/files/active/resources/pre ss_releases/PressRelease-CamarenaWilliams-October2013.pdf10/4/2013
Statement From USADA CEO, Travis T. Tygart, Regarding Today's UCI Election Results September 27, 2013

"USADA welcomes cycling’s vote for a new and clean future.  The outcome of the UCI election sends a powerful message that sport leaders who fail to fully protect the rights of clean athletes and the integrity of their sport will be held accountable.  The UCI tried to obstruct our investigation into doping in cycling at every turn, and then after the release of our reasoned decision the previous leadership failed to take necessary and decisive action to fully clean up the sport. The election of a new UCI President who is committed to transparency and a new direction, is a monumental moment for the sport and demonstrates that when clean athletes stand up for their rights they will be heard.


We are confident that as President, Mr. Cookson will take the decisive action needed, so that cycling can truly unshackle itself from the past and pursue a clean culture for future generations of cyclists."

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

─ # ─

CONTACT:
Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org

]]>
http://www.usada.org/files/active/resources/pre ss_releases/ 9/27/2013
US Paralympic Track & Field Athlete, Crouse, Receives Sanction For Anti-Doping Rule Violation September 23, 2013

USADA announced today that Camdin Crouse, of Snow Shoe, Pa., an athlete in the sport of Paralympic track & field, has tested positive for prohibited substances and received a two-year suspension for his doping offense.

Crouse, 25, tested positive for Amphetamine and Methylhexaneamine as the result of an in-competition urine sample collected on June 14, 2013 at the U.S. Paralympic Track & Field National Championships in San Antonio, Texas. Amphetamine and Methylhexaneamine are Stimulants prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and International Paralympic Committee (“IPC”) Anti‐Doping Code, both of which have adopted the World Anti-Doping Code (“Code”) and the World Anti-Doping Agency Prohibited List.

Crouse’s two-year period of ineligibility began on August 8, 2013, the date a provisional suspension was imposed. As a result of the violation, Crouse has been disqualified from all competitive results achieved on and subsequent to June 14, 2013, the date his sample was collected, including forfeiture of any medals, points, and prizes.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

─ # ─

CONTACT:
Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org

]]>
http://www.usada.org/files/active/resources/pre ss_releases/Press Release-Crouse-September 2013.pdf9/23/2013